A New Way of Measuring Health Costs Sheds Light on Recent Health Spending Trends March 29, 2016 Issue Brief National health spending started to grow more rapidly recently after several years of unusually slow growth. This analysis from the Kaiser Family Foundation and the federal Bureau of Economic Analysis helps to dissect why that may be happening. Using recently-released disease-based health spending data compiled by the federal government, the analysis finds…
How High Drug Prices Weigh on the Sickest Americans December 28, 2015 Perspective In this column for The Wall Street Journal’s Think Tank, Drew Altman explores the data behind public concern about prescription drug costs and highlights that the people most in need are the most burdened by the problem.
Prescription Drugs’ Sizable Share of Health Spending December 14, 2015 News Release In his latest column for The Wall Street Journal‘s Think Tank, Drew Altman explains why prescription drug spending may be a larger share of health spending than most people think, depending on how you look at it. All previous columns by Drew Altman are online.
Prescription Drugs’ Sizable Share of Health Spending December 13, 2015 Perspective In this column for The Wall Street Journal’s Think Tank, Drew Altman explains why prescription drug spending may be a larger share of health spending than most people think, depending on how you look at it.
Why Higher Drug Costs Are Consumers’ Biggest Cost Worry September 8, 2015 News Release In his latest column for The Wall Street Journal’s Think Tank, Drew Altman discusses why public concern over drug prices is the “tip of the iceberg” representing broader concerns about out-of-pocket health care costs. All previous columns by Drew Altman are available online.
Why Higher Drug Costs Are Consumers’ Biggest Cost Worry September 8, 2015 Perspective In this column for The Wall Street Journal’s Think Tank, Drew Altman discusses why public concern over drug prices is the “tip of the iceberg” representing broader concerns about out-of-pocket health care costs.
Americans’ Health Priorities Diverge From Washington’s Focus on Obamacare May 4, 2015 News Release In his latest column for The Wall Street Journal’s Think Tank, Drew Altman finds the public’s health-care priorities have more to do with drug costs and other real-world issues people deal with using the health-care system than the ongoing partisan wrangling over the Affordable Care Act. All previous columns by Drew Altman are available…
Americans’ Health Priorities Diverge From Washington’s Focus on Obamacare May 4, 2015 Perspective In this column for The Wall Street Journal’s Think Tank, Drew Altman finds the public’s healthcare priorities have more to do with drug costs and other real world issues people deal with using the health care system than the ongoing partisan wrangling over the Affordable Care Act (ACA).
Few Consumers Use Information on Health Provider Quality or Price April 27, 2015 News Release In his latest column for The Wall Street Journal’s Think Tank, Drew Altman discusses new poll findings showing very small numbers of consumers are using provider quality and price information. All previous columns by Drew Altman are available online.
